Risk Factors for Death in 632 Patients with Sickle Cell Disease in the United States and United Kingdom

• Mark T. Gladwin ,

  * E-mail: gladwinmt@upmc.edu

  Affiliations Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America, Division of Pulmonary Allergy and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Robyn J. Barst,

  Affiliation Columbia University, New York, New York, United States of America

  ⨯
• J. Simon R. Gibbs,

  Affiliation National Heart & Lung Institute, Imperial College London, London, United Kingdom

  ⨯
• Mariana Hildesheim,

  Affiliations Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America, Division of Pulmonary Allergy and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Vandana Sachdev,

  Affiliation Cardiovascular Branch, NHLBI, Bethesda, Maryland, United States of America

  ⨯
• Mehdi Nouraie,

  Affiliation Howard University, Washington, DC, United States of America

  ⨯
• Kathryn L. Hassell,

  Affiliation University of Colorado HSC, Denver, Colorado, United States of America

  ⨯
• Jane A. Little,

  Affiliation Case Western Reserve University, Cleveland, Ohio, United States of America

  ⨯
• Dean E. Schraufnagel,

  Affiliation University of Illinois, Chicago, Illinois, United States of America

  ⨯
• Lakshmanan Krishnamurti,

  Affiliations Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Enrico Novelli,

  Affiliation Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Reda E. Girgis,

  Affiliation Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Claudia R. Morris,

  Affiliation Emory University School of Medicine, Atlanta, Georgia, United States of America

  ⨯
• Erika Berman Rosenzweig,

  Affiliation Columbia University, New York, New York, United States of America

  ⨯
• David B. Badesch,

  Affiliation University of Colorado HSC, Denver, Colorado, United States of America

  ⨯
• Sophie Lanzkron,

  Affiliation Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Oswaldo L. Castro,

  Affiliation Howard University, Washington, DC, United States of America

  ⨯
• James G. Taylor VI,

  Affiliation Cardiovascular Branch, NHLBI, Bethesda, Maryland, United States of America

  ⨯
• Jonathan C. Goldsmith,

  Affiliation National Heart Lung and Blood Institute/NIH, Bethesda, Maryland, United States of America

  ⨯
• Gregory J. Kato,

  Affiliation Cardiovascular Branch, NHLBI, Bethesda, Maryland, United States of America

  ⨯
• Victor R. Gordeuk,

  Affiliation University of Illinois, Chicago, Illinois, United States of America

  ⨯
• Roberto F. Machado,

  Affiliation University of Illinois, Chicago, Illinois, United States of America

  ⨯
•  [ ... ],
• on behalf of the walk-PHaSST Investigators and Patients
• [ view all ]
• [ view less ]